Oxidative stress in Duchenne muscular dystrophy: focus on the NRF2 redox pathway
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oxidative stress in Duchenne muscular dystrophy: focus on the NRF2 redox pathway
Authors
Keywords
-
Journal
HUMAN MOLECULAR GENETICS
Volume 26, Issue 14, Pages 2781-2790
Publisher
Oxford University Press (OUP)
Online
2017-05-03
DOI
10.1093/hmg/ddx173
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
- (2016) Isabel Lastres-Becker et al. ANTIOXIDANTS & REDOX SIGNALING
- Nrf2 regulates ROS production by mitochondria and NADPH oxidase
- (2015) Stjepana Kovac et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease
- (2015) Lauren E. Tebay et al. FREE RADICAL BIOLOGY AND MEDICINE
- Increased levels of interleukin-6 exacerbate the dystrophic phenotype in mdx mice
- (2015) Laura Pelosi et al. HUMAN MOLECULAR GENETICS
- Sulforaphane alleviates muscular dystrophy in mdx mice by activation of Nrf2
- (2015) Chengcao Sun et al. JOURNAL OF APPLIED PHYSIOLOGY
- Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficientmdxMice via NF-E2-related Factor 2 (Nrf2)-mediated Inhibition of NF-κB Signaling Pathway
- (2015) Cheng-Cao Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial
- (2015) Gunnar M Buyse et al. LANCET
- A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy
- (2015) Nicholas P. Whitehead et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
- (2014) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies
- (2013) Jessica R. Terrill et al. FEBS Journal
- Protein carbonylation and muscle function in COPD and other conditions
- (2013) Esther Barreiro MASS SPECTROMETRY REVIEWS
- Analysis of GSH and GSSG after derivatization with N-ethylmaleimide
- (2013) Daniela Giustarini et al. Nature Protocols
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
- (2012) Paul D. Ray et al. CELLULAR SIGNALLING
- Emerging drugs for Duchenne muscular dystrophy
- (2012) Vinod Malik et al. EXPERT OPINION ON EMERGING DRUGS
- X-ROS signaling in the heart and skeletal muscle: Stretch-dependent local ROS regulates [Ca2+]i
- (2012) Benjamin L. Prosser et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Oxidative Damage in Muscular Dystrophy Correlates with the Severity of the Pathology: Role of Glutathione Metabolism
- (2012) R. Renjini et al. NEUROCHEMICAL RESEARCH
- Increased muscle expression of interleukin-17 in Duchenne muscular dystrophy
- (2012) L. De Pasquale et al. NEUROLOGY
- Effects of glucocorticoids and idebenone on respiratory function in patients with duchenne muscular dystrophy
- (2012) Gunnar M. Buyse et al. PEDIATRIC PULMONOLOGY
- Protein carbonylation and metabolic control systems
- (2012) Jessica M. Curtis et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- S-Glutathionylation: From Molecular Mechanisms to Health Outcomes
- (2011) Ying Xiong et al. ANTIOXIDANTS & REDOX SIGNALING
- Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
- (2011) Ralf A. Linker et al. BRAIN
- Resveratrol Ameliorates Muscular Pathology in the Dystrophic mdx Mouse, a Model for Duchenne Muscular Dystrophy
- (2011) Y. S. Hori et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: Results from a 12 month, double-blind, randomized placebo-controlled trial
- (2011) Gunnar M. Buyse et al. NEUROMUSCULAR DISORDERS
- N-Acetylcysteine treatment of dystrophic mdx mice results in protein thiol modifications and inhibition of exercise induced myofibre necrosis
- (2011) Jessica R. Terrill et al. NEUROMUSCULAR DISORDERS
- X-ROS Signaling: Rapid Mechano-Chemo Transduction in Heart
- (2011) B. L. Prosser et al. SCIENCE
- Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential
- (2010) Ananta Paine et al. BIOCHEMICAL PHARMACOLOGY
- Increased catalase expression improves muscle function inmdxmice
- (2010) Joshua T. Selsby EXPERIMENTAL PHYSIOLOGY
- Skeletal Muscle NADPH Oxidase Is Increased and Triggers Stretch-Induced Damage in the mdx Mouse
- (2010) Nicholas P. Whitehead et al. PLoS One
- Green tea extract decreases muscle pathology and NF-κB immunostaining in regenerating muscle fibers of mdx mice
- (2009) Nicholas P. Evans et al. CLINICAL NUTRITION
- Molecular Mechanisms and Clinical Implications of Reversible Protein S-Glutathionylation
- (2008) John J. Mieyal et al. ANTIOXIDANTS & REDOX SIGNALING
- Subcutaneous injection, from birth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular dystrophy in mdx mice: a quantitative histological, immunohistochemical and electrophysiological study
- (2008) Yoshiko Nakae et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extract
- (2008) Jarrod A. Call et al. JOURNAL OF APPLIED PHYSIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now